Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122697) titled 'Survey on treatment patterns and patient experience among myeloproliferative neoplasm patients' on April 16.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Condition:
Myeloproliferative Neoplasms (Essential Thrombocythemia, Polycythemia Vera)
Intervention:
Hematology Physicians:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-29
Target Sample Size: Hematology Physicians:100;Patients:50;
Countries of Recruitment:
China
To know more, visit http...